Results for “”

Entry Author Date Location
Bio Roundup: Spark’s Road Ahead, Juno Rumors, Merck’s Big Day & More 01/19/18 National
Absences, Surprises in Amazon’s Final List of 20 Cities for HQ2 01/18/18 Seattle
In “Age of Amazon,” All Retailers Are Tech Companies, Even Walmart 01/17/18 National
Merck Is Latest to Tout Success as Lung Cancer Drug Combos Plow Forward 01/16/18 New York
Spark CEO Marrazzo on Gene Therapy Pricing & Paving the Way for the Field 01/12/18 National
Bio Roundup: #JPM18, Axovant’s Fall, CRISPR Caveat, Impact M&A & More 01/12/18 National
Notes From the JPM ’18 Vortex: Gene Therapy’s Reckoning and Lonely Cabs 01/11/18 National
Eye Drug Delivery Firm Eyenovia Sets IPO Range as Plans Come Into Focus 01/10/18 New York
Venture Activity Comes to (Unicorn) Point in 2017, and Top 10 Deals 01/09/18 National
Chet Kanojia Paints Vision of a New Kind of ISP at Starry Internet 01/08/18 Boston
After 2nd Bet on Familiar Drug, Impact Bio Lands $1B Celgene Buyout 01/07/18 San Diego
Bio Roundup: Trump, Gottlieb, Gene Therapy Prices, IPO Hopes & More 01/05/18 National
Gene Therapy 2.0: New Startups Aim to Fine-Tune Gene Delivery and Control 01/04/18 Boston
Clean Energy Entrepreneur Desai on Tech’s Pitfalls & Promise in 2017 01/03/18 Texas
First U.S. Gene Therapy, Approved for Vision Loss, to Cost $850,000 01/03/18 National
Trump v. Drug Makers? And 6 More Burning Biopharma Questions for 2018 01/02/18 National
Six Useful Things You Can Do With Your New Smart Speaker 01/02/18 National
Family & Kids’ Advocate Shum Preston on the Tech Backlash of 2017 01/02/18 San Francisco
Houston Investor Murthy Reflects on Tech’s High & Low Points in 2017 12/29/17 Texas
Security Evangelist Tony Anscombe on the Tech Backlash of 2017 12/29/17 San Diego
UTD’s Guengerich on the Promise and Peril of Tech Innovation in 2017 12/28/17 Texas
WatchHerWork CEO Hamilton: “We Are All Ready for Tech to Grow Up” 12/27/17 Texas
Despite Scandal-Filled Year, Mark Cuban Says “Tech Is Just Tech” 12/26/17 Texas
Cybersecurity Expert Ash Mozano on the Tech Backlash of 2017 12/26/17 San Diego
Roche Bets $1.7B More on Precision Oncology With Ignyta Deal 12/22/17 San Diego
Bio Roundup: Tax Cuts, Drug Approval Record, New Flagship Cash & More 12/22/17 National
Xconomy Award Winner Vicki Sato on How to Build Biotech in New York 12/21/17 New York
Stop Being an “Initiative”: Highlights From NY Biotech—The Future Is Now 12/20/17 New York
Two Months Ahead of Schedule, FDA Clears Aerie Glaucoma Drug 12/19/17 New York
Bio Roundup: Tax Cuts, a Funding Rush, Hemophilia Questions & More 12/15/17 National
Page 1 of 67 next page »